1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

OLMA
Olema Pharmaceuticals, Inc.US flagNASDAQ Global Select
11.59
USD
+0.24
- -
1.01BMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
2
4
22
71
107
105
142
179
+ Selling, General & Admin
- -
- -
8
20
25
19
18
21
+ Research & Development
2
4
14
51
82
86
125
158
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-2
-4
-22
-71
-107
-105
-142
-179
- Non-Operating (Income) Loss
- -
- -
1
- -
-2
-8
-13
-16
+ Interest Expense, Net
- -
- -
1
- -
-2
-8
-13
-16
+ Interest Expense
- -
- -
1
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
2
8
13
16
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
- -
Pretax Income
-2
-4
-22
-71
-105
-97
-129
-162
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-2
-4
-22
-71
-105
-97
-129
-162
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-2
-4
-22
-71
-105
-97
-129
-162
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-4
-22
-71
-105
-97
-129
-162
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-2
-4
-22
-71
-105
-97
-129
-162
EBIT
-2
-4
-22
-71
-107
-105
-142
-179
EBITDA
-2
-4
-22
-71
-107
-105
-142
-178
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-2
-4
-22
-71
-107
-105
-142
-179
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
14
14
7
40
40
45
59
87
Basic EPS, GAAP
-0.16
-0.31
-3.15
-1.8
-2.62
-2.14
-2.2
-1.87
Basic EPS from Cont Ops
-0.16
-0.31
-3.15
-1.8
-2.62
-2.14
-2.2
-1.87
Diluted Weighted Avg Shares
14
14
7
40
40
45
59
87
Diluted EPS, GAAP
-0.16
-0.31
-3.15
-1.8
-2.62
-2.14
-2.2
-1.87
Diluted EPS from Cont Ops
-0.16
-0.31
-3.15
-1.8
-2.62
-2.14
-2.2
-1.87

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
3
- -
342
291
209
267
438
515
+ Cash, Cash Equivalents & STI
3
- -
339
287
204
262
434
505
+ Cash & Cash Equivalents
3
- -
339
14
24
69
139
48
+ ST Investments
- -
- -
- -
273
181
193
295
457
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
1
2
4
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
1
2
4
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
4
3
4
4
2
6
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
5
7
10
13
18
+ Property, Plant & Equip, Net
- -
- -
- -
5
3
3
2
1
+ Property, Plant & Equip
- -
- -
- -
5
4
3
2
1
- Accumulated Depreciation
- -
- -
- -
- -
1
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
1
3
7
10
17
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
1
3
7
10
17
Total Assets
3
- -
343
296
216
277
451
533
+ Payables & Accruals
- -
1
3
4
11
15
35
42
+ Accounts Payable
- -
1
1
- -
- -
3
4
9
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
2
4
10
12
30
33
+ ST Debt
- -
- -
- -
1
1
1
1
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
1
1
1
1
1
+ Other ST Liabilities
- -
- -
2
4
5
5
6
8
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
2
4
5
5
6
8
Total Current Liabilities
- -
1
5
9
17
22
42
52
+ LT Debt
- -
- -
- -
2
2
1
- -
3
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
3
+ LT Finance Leases
- -
- -
- -
2
2
1
- -
- -
+ Other LT Liabilities
9
9
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
9
9
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
9
9
- -
2
2
1
- -
3
Total Liabilities
10
11
5
11
18
23
42
55
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
371
389
408
559
844
1,075
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
371
389
408
559
844
1,075
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-6
-11
-33
-104
-209
-306
-435
-598
+ Other Equity
- -
- -
- -
- -
-2
- -
- -
1
Equity Before Minority Interest
-6
-11
338
285
198
254
409
479
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-6
-11
338
285
198
254
409
479
Total Liabilities & Equity
3
- -
343
296
216
277
451
533
Shares Outstanding
38
38
39
40
40
55
74
81
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
3
3
2
1
1
Net Debt
-3
- -
-339
-14
-24
-69
-139
-45
Net Debt to Equity
50.16
0.64
-100.12
-4.85
-12
-27
-34.11
-9.47
Tangible Common Equity Ratio
-191.93
-8,025.76
98.66
96.16
91.61
91.68
90.68
89.71
Current Ratio
16.13
0.07
74.62
32.23
12.62
12.33
10.5
9.95
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-2
-4
-22
-71
-105
-97
-129
-162
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
4
17
19
13
16
12
+ Stock-Based Compensation
- -
- -
3
16
19
17
23
18
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
1
2
1
-4
-7
-5
+ Chg in Non-Cash Work Cap
- -
1
-2
3
3
-1
9
3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-4
- -
-2
1
- -
-5
+ Inc (Dec) in Accts Payable
- -
1
- -
-1
- -
2
3
5
+ Inc (Dec) in Other
- -
- -
2
4
5
-4
7
4
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-2
-3
-20
-51
-82
-84
-104
-147
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-2
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
-2
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
221
- -
- -
130
266
205
+ Increase in Capital Stock
- -
- -
221
- -
- -
130
266
205
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
-274
92
-5
-93
-156
+ Dec in LT Investment
- -
- -
- -
213
306
251
302
345
+ Inc in LT Investment
- -
- -
- -
-487
-214
-256
-395
-501
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
-275
91
-5
-94
-156
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
3
- -
- -
- -
- -
3
+ Cash From Debt
- -
- -
3
- -
- -
- -
- -
3
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
5
- -
135
1
- -
4
3
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
5
- -
358
1
- -
133
269
211
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
3
-3
338
-325
10
45
71
-91
EBITDA
-2
-4
-22
-71
-107
-105
-142
-178
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-2
-3
-20
-52
-82
-84
-105
-147
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-3
-17
-52
-82
-84
-105
-144
Free Cash Flow per Basic Share
-0.15
-0.22
-2.84
-1.32
-2.06
-1.85
-1.78
-1.69
Price/Free Cash Flow
- -
- -
-17.04
-7.53
-1.2
-7.58
-3.29
-14.83
Cash Flow to Net Income
0.99
0.71
0.9
0.71
0.78
0.87
0.81
0.9
Capital Expenditures
- -
- -
- -
-2
- -
- -
- -
- -